“…1 Although most do not require treatment, tumors with rapid growth may be predisposed to acute hemorrhage, and others may require treatment for suppression of endocrine function or for size reduction. 1,4 Clinical decision-making during monitoring of these tumors should focus on these factors, and particularly tumor size, when considering the risk for spontaneous hemorrhage. For example, in a case report of 75 patients with diagnosed ML, the incidence of hemorrhage was associated with larger masses (14.4 cm vs. 10.4 cm).…”